Should cervical favourability play a role in the decision for labour induction in gestational hypertension or mild pre-eclampsia at term? An exploratory analysis of the HYPITAT trial

BJOG. 2012 Aug;119(9):1123-30. doi: 10.1111/j.1471-0528.2012.03405.x. Epub 2012 Jun 18.

Abstract

Objective: To examine whether cervical favourability (measured by cervical length and the Bishop score) should inform obstetricians' decision regarding labour induction for women with gestational hypertension or mild pre-eclampsia at term.

Design: A post hoc analysis of the Hypertension and Pre-eclampsia Intervention Trial At Term (HYPITAT).

Setting: Obstetric departments of six university and 32 teaching and district hospitals in the Netherlands.

Population: A total of 756 women diagnosed with gestational hypertension or pre-eclampsia between 36 + 0 and 41 + 0 weeks of gestation randomly allocated to induction of labour or expectant management.

Methods: Data were analysed using logistic regression modelling.

Main outcome measures: The occurrence of a high-risk maternal situation defined as either maternal complications or progression to severe disease. Secondary outcomes were caesarean delivery and adverse neonatal outcomes.

Results: The superiority of labour induction in preventing high-risk situations in women with gestational hypertension or mild pre-eclampsia at term varied significantly according to cervical favourability. In women who were managed expectantly, the longer the cervix the higher the risk of developing maternal high-risk situations, whereas in women in whom labour was induced, cervical length was not associated with a higher probability of maternal high-risk situations (test of interaction P = 0.03). Similarly, the beneficial effect of labour induction on reducing the caesarean section rate was stronger in women with an unfavourable cervix.

Conclusion: Against widely held opinion, our exploratory analysis showed that women with gestational hypertension or mild pre-eclampsia at term who have an unfavourable cervix benefited more from labour induction than other women.

Trial registration: The trial has been registered in the clinical trial register as ISRCTN08132825.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cervical Ripening / physiology*
  • Cesarean Section / statistics & numerical data
  • Decision Making
  • Delivery, Obstetric
  • Female
  • Gestational Age
  • Humans
  • Hypertension, Pregnancy-Induced / therapy*
  • Labor, Induced / methods*
  • Pre-Eclampsia / therapy
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy, High-Risk

Associated data

  • ISRCTN/ISRCTN08132825